The macular carotenoids lutein (L), zeaxanthin (Z) and meso-zeaxanthin
(MZ) accumulate at the macula, where they are collectively referred to as macular pigment
(MP). Augmentation of this pigment, typically achieved through diet and supplementation,
enhances visual function and protects against progression of age-related macular
degeneration. However, it is known that eggs are a rich dietary source of L and Z, in a
highly bioavailable matrix. In this single-blind placebo-controlled study, L- and
MZ-enriched eggs and control non-enriched eggs were fed to human subjects (mean age 41 and
35 years, respectively) over an 8-week period, and outcome measures included MP, visual
function and serum concentrations of carotenoids and cholesterol. Serum carotenoid
concentrations increased significantly in control and enriched egg groups, but to a
significantly greater extent in the enriched egg group (P<0·001
for L, Z and MZ). There was no significant increase in MP in either study group post
intervention, and we saw no significant improvement in visual performance in either group.
Total cholesterol increased significantly in each group, but it did not exceed the upper
limit of the normative range (6·5 mmol/l). Therefore, carotenoid-enriched eggs may
represent an effective dietary source of L, Z and MZ, reflected in significantly raised
serum concentrations of these carotenoids, and consequentially improved bioavailability
for capture by target tissues. However, benefits in terms of MP augmentation and /or
improved visual performance were not realised over the 8-week study period, and a study of
greater duration will be required to address these questions.